Cargando…

DR2 blocker thioridazine: A promising drug for ovarian cancer therapy

Detalles Bibliográficos
Autores principales: Yong, Min, Yu, Tinghe, Tian, Si, Liu, Shuaibin, Xu, Jiao, Hu, Jianguo, Hu, Lina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491036/
https://www.ncbi.nlm.nih.gov/pubmed/32963624
http://dx.doi.org/10.3892/ol.2020.12081
_version_ 1783582138690437120
author Yong, Min
Yu, Tinghe
Tian, Si
Liu, Shuaibin
Xu, Jiao
Hu, Jianguo
Hu, Lina
author_facet Yong, Min
Yu, Tinghe
Tian, Si
Liu, Shuaibin
Xu, Jiao
Hu, Jianguo
Hu, Lina
author_sort Yong, Min
collection PubMed
description
format Online
Article
Text
id pubmed-7491036
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-74910362020-09-21 DR2 blocker thioridazine: A promising drug for ovarian cancer therapy Yong, Min Yu, Tinghe Tian, Si Liu, Shuaibin Xu, Jiao Hu, Jianguo Hu, Lina Oncol Lett Corrigendum D.A. Spandidos 2020-11 2020-09-09 /pmc/articles/PMC7491036/ /pubmed/32963624 http://dx.doi.org/10.3892/ol.2020.12081 Text en Copyright: © Yong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Corrigendum
Yong, Min
Yu, Tinghe
Tian, Si
Liu, Shuaibin
Xu, Jiao
Hu, Jianguo
Hu, Lina
DR2 blocker thioridazine: A promising drug for ovarian cancer therapy
title DR2 blocker thioridazine: A promising drug for ovarian cancer therapy
title_full DR2 blocker thioridazine: A promising drug for ovarian cancer therapy
title_fullStr DR2 blocker thioridazine: A promising drug for ovarian cancer therapy
title_full_unstemmed DR2 blocker thioridazine: A promising drug for ovarian cancer therapy
title_short DR2 blocker thioridazine: A promising drug for ovarian cancer therapy
title_sort dr2 blocker thioridazine: a promising drug for ovarian cancer therapy
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491036/
https://www.ncbi.nlm.nih.gov/pubmed/32963624
http://dx.doi.org/10.3892/ol.2020.12081
work_keys_str_mv AT yongmin dr2blockerthioridazineapromisingdrugforovariancancertherapy
AT yutinghe dr2blockerthioridazineapromisingdrugforovariancancertherapy
AT tiansi dr2blockerthioridazineapromisingdrugforovariancancertherapy
AT liushuaibin dr2blockerthioridazineapromisingdrugforovariancancertherapy
AT xujiao dr2blockerthioridazineapromisingdrugforovariancancertherapy
AT hujianguo dr2blockerthioridazineapromisingdrugforovariancancertherapy
AT hulina dr2blockerthioridazineapromisingdrugforovariancancertherapy